Clementia Pharmaceuticals Inc.

This study is testing whether an oral medication called fidrisertib can slow the formation of new, abnormal bone in people with Fibrodysplasia Ossificans Progressiva (FOP), a rare and severely disabling disease. It will compare two different doses of the drug against a placebo in…